(Q40660015)
Statements
A phase I and pharmacological study of topotecan infused over 30 minutes for five days in patients with refractory acute leukemia (English)
Rowinsky EK
Baker SD
Miller CB
Sartorius SE
Bowling MK
Chen TL
Donehower RC
1 December 1996